Skin hepcidin initiates psoriasiform skin inflammation via Fe-driven hyperproliferation and neutrophil recruitment - (https:/ ...

Scientists may have uncovered the root cause of psoriasis, a chronic and sometimes debilitating skin disease that affects 2–3 ...

Scientists may have uncovered the root cause of psoriasis, a chronic and sometimes debilitating skin disease that affects 2-3% of the global ...

Scientists believe the hormone hepcidin, when produced in the skin, may be the root cause of psoriasis -- a chronic and sometimes debilitating skin disease that affects 2-3% of the global population.

Tiny blisters can form as fluids beneath the skin start to pool. A rare form of psoriasis, known as pustular psoriasis, can cause white or yellow blisters filled with pus. When it affects the feet, it ...

In relapsed ALL cases, the most prominent source of new mutations was exposure to thiopurine Multiple mutational processes usually act in parallel as prominent secondary drivers with dynamic activity ...

The link between streptococcal tonsillitis and first onset of psoriasis is well known. Here we show that streptococcal infection is confined to a particular subtype of non-pustular psoriasis, which is ...

The most frequently reported serious adverse event was pustular psoriasis (seen as worsening of the disease under investigation), reported for three (3·2%) of 92 receiving spesolimab with one patient ...

cDepartment of Dermatology, Stony Brook School of Medicine, Stony Brook, NY, USA dDepartment of Dermatology, Reno School of Medicine, University of Nevada, Reno, NV, USA ...

Inverse psoriasis develops in the armpits, groin, under the breasts, and other skin folds. Pustular psoriasis White or yellow blisters form on the skin. They often develop on the hands and feet.

A chest CT is a valuable investigative tool in patients who have been diagnosed with systemic mastocytosis. Approximately one-third of patients with systemic mastocytosis (SM) have bronchial or lung ...

The US Food and Drug Administration (FDA) has granted approval for Boehringer Ingelheim's SPEVIGO injection to treat generalised pustular psoriasis (GPP). The treatment is indicated for use in adult ...